Aspire Biopharma Holdings (ASBP) Preferred Shares (2024 - 2026)

Aspire Biopharma Holdings (ASBP) posted quarterly Preferred Shares of $1.0 for Q1 2026, down 96.88% quarter-over-quarter from $32.0 in Q4 2024.

Aspire Biopharma Holdings (ASBP) Preferred Shares (2024 - 2026) Analysis & Trends

Aspire Biopharma Holdings (ASBP) has reported Preferred Shares for 2 consecutive years, with $1.0 the latest figure, recorded in Q1 2026.

In Q1 2026, Preferred Shares changed N/A year-over-year to $1.0; the TTM figure through Mar 2026 stood at $1.0 (changed N/A YoY), while the FY2024 annual figure was $32.0, changed N/A from the prior year.
Preferred Shares slipped to $1.0 in Q1 2026 per ASBP's latest filing, from $32.0 in the prior quarter.
Across five years, Preferred Shares topped out at $32.0 in Q4 2024 and bottomed at $1.0 in Q1 2026.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Aspire Biopharma Holdings	8.30 Mn	-3.86 Mn	-30,086.00	2.00

Download Data